1. Home
  2. CCBG vs MGTX Comparison

CCBG vs MGTX Comparison

Compare CCBG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital City Bank Group

CCBG

Capital City Bank Group

HOLD

Current Price

$51.83

Market Cap

877.0M

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$11.73

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCBG
MGTX
Founded
1895
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
877.0M
909.1M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CCBG
MGTX
Price
$51.83
$11.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$50.00
$24.57
AVG Volume (30 Days)
96.3K
1.0M
Earning Date
04-20-2026
05-12-2026
Dividend Yield
2.34%
N/A
EPS Growth
15.38
33.02
EPS
0.92
N/A
Revenue
N/A
$81,391,000.00
Revenue This Year
$6.25
$141.38
Revenue Next Year
$3.17
N/A
P/E Ratio
$55.38
N/A
Revenue Growth
N/A
144.57
52 Week Low
$38.02
$6.62
52 Week High
$52.22
$15.35

Technical Indicators

Market Signals
Indicator
CCBG
MGTX
Relative Strength Index (RSI) 63.38 45.68
Support Level $44.48 $8.66
Resistance Level N/A $11.85
Average True Range (ATR) 1.51 0.83
MACD 0.08 -0.26
Stochastic Oscillator 88.67 0.00

Price Performance

Historical Comparison
CCBG
MGTX

About CCBG Capital City Bank Group

Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: